(c) 2024 PillSync.com

gabapentin 600 MG Oral Tablet

INDICATIONS AND USAGE Postherpetic Neuralgia Gabapentin tablets, USP are indicated for the Management of postherpetic neuralgia in adults. Epilepsy Gabapentin tablets, USP are indicated as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in patients over 12 years of age with epilepsy. Gabapentin tablets are also indicated as adjunctive therapy in the treatment of partial seizures in pediatric patients age 3 to 12 years.

Sun Pharmaceutical Industries Limited


5 years ago OVAL WHITE 202 gabapentin 600 MG Oral Tablet

OVAL WHITE 202

HOW SUPPLIED Gabapentin tablets, USP are supplied as follows: 600 mg tablets; white to off white, biconvex, oval shape, coated tablet scored on both sides and debossed with “202” on one side, available in: Bottles of 100: Child Resistant Cap. NDC 62756-202-01 Non Child Resistant Cap. NDC 62756-202-02 Bottles of 500: Non Child Resistant Cap. NDC 62756-202-03 Unit dose 50’s: NDC 62756-202-04 800 mg tablets; white to off white, biconvex, oval shape, coated tablet scored on both sides and debossed with “204” on one side, available in: Bottles of 100: Child Resistant Cap. NDC 62756-204-01 Non Child Resistant Cap. NDC 62756-204-02 Bottles of 500: Non Child Resistant Cap. NDC 62756-204-03 Unit dose 50’s: NDC 62756-204-04 Storage Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature].


More pills like OVAL 202












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site